North Media A/S
Company announcement No 03-2021
11 February 2021
Pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them must notify the Danish Financial Supervisory Authority and notify North Media A/S of transactions related to shares in North Media A/S.
North Media A/S hereby makes public pursuant to article 19 of regulation (EU) no. 596/2014 of the European Parliament and of the Council on market abuse the following information received from persons discharging managerial responsibilities in North Media A/S and/or persons closely related with them (see attached).
The transactions are:
Name | Holdings before transaction, no. of shares | Transaction, no. of shares | Holdings after transaction, no. of shares |
Ole Elverdam Borch (acquisition) | 0 | 3,150 | 3,150 |
For further information
Kåre Wigh, Group Executive Director & CFO, mobile +45 25 65 21 45
This document is an unofficial translation of the Danish original. In the event of any inconsistencies, the Danish version shall apply.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Wolters Kluwer N.V.19.9.2025 08:00:00 CEST | Press release
Wolters Kluwer completes capital reduction
Orion Oyj19.9.2025 08:00:00 CEST | Press release
80,802 Orion Corporation A shares converted into B shares
JDE Peet's N.V.19.9.2025 07:55:00 CEST | Press release
Update on intended recommended public offer by KDP for JDE Peet's
Sampo plc19.9.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 18 September 2025
Idorsia Pharmaceuticals Ltd19.9.2025 07:00:00 CEST | Press release
Idorsia’s JERAYGO (aprocitentan) approved in Switzerland for the treatment of resistant hypertension
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom